Justus Duyster

17.0k total citations · 1 hit paper
261 papers, 9.0k citations indexed

About

Justus Duyster is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Justus Duyster has authored 261 papers receiving a total of 9.0k indexed citations (citations by other indexed papers that have themselves been cited), including 143 papers in Hematology, 81 papers in Genetics and 77 papers in Molecular Biology. Recurrent topics in Justus Duyster's work include Chronic Myeloid Leukemia Treatments (85 papers), Chronic Lymphocytic Leukemia Research (58 papers) and Acute Myeloid Leukemia Research (56 papers). Justus Duyster is often cited by papers focused on Chronic Myeloid Leukemia Treatments (85 papers), Chronic Lymphocytic Leukemia Research (58 papers) and Acute Myeloid Leukemia Research (56 papers). Justus Duyster collaborates with scholars based in Germany, United States and Switzerland. Justus Duyster's co-authors include Christian Peschel, Nikolas von Bubnoff, Cornelius Miething, Stephan W. Morris, Ren-Yuan Bai, Folker Schneller, Rebekka Grundler, Rama Krishna Kancha, Katja Zirlik and Peter Dieter and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Justus Duyster

253 papers receiving 8.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

NF-κB Is a Negative Regulator of IL-1β Secretion as Revealed by Genetic and Pharmacological Inhibition of IKKβ

2007 503 citations Cornelius Miething, Justus Duyster et al. profile →

Peers

Countries citing papers authored by Justus Duyster

Since Specialization

Citations

This map shows the geographic impact of Justus Duyster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Justus Duyster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Justus Duyster more than expected).

Fields of papers citing papers by Justus Duyster

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Justus Duyster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Justus Duyster. The network helps show where Justus Duyster may publish in the future.

Co-authorship network of co-authors of Justus Duyster

This figure shows the co-authorship network connecting the top 25 collaborators of Justus Duyster. A scholar is included among the top collaborators of Justus Duyster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Justus Duyster. Justus Duyster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Genetic and epigenetic alterations at secondary resistance after continued decitabine-based treatment of acute myeloid leukemia in the randomized phase II DECIDER trial 2025 ·Leukemia ·(unknown), (unknown), Geoffroy Andrieux, (unknown), Gabriele Greve, (unknown), (unknown), (unknown), (unknown), Felicitas Thol, Michael Heuser, Gesine Bug, Martina Crysandt, Andreas Neubauer, Justus Duyster, Hartmut Döhner, Melanie Boerries, Michael Lübbert, Heiko Becker	0
2	Immunological reconstitution and infections after alloHCT - a comparison between post-transplantation cyclophosphamide, ATLG and non-ATLG based GvHD prophylaxis 2024 ·Bone Marrow Transplantation ·Thomas Meyer, Kristina Maas‐Bauer, Ralph Wäsch, Justus Duyster, Robert Zeiser, Jürgen Finke, Claudia Wehr	2
3	Long-term follow-up of patients with acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation after primary induction failure 2023 ·Blood Cancer Journal ·(unknown), Gabriele Ihorst, Jesús Duque‐Afonso, Ralph Wäsch, Hartmut Bertz, Claudia Wehr, Justus Duyster, Robert Zeiser, Jürgen Finke, Florian Scherer	5
4	The antileukemic activity of decitabine upon PML/RARA-negative AML blasts is supported by all-trans retinoic acid: in vitro and in vivo evidence for cooperation 2022 ·Blood Cancer Journal ·(unknown), Gabriele Greve, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Lars Feuerbach, Daniel B. Lipka, Joschka Hey, Björn Grüning, Benedikt Brors, Justus Duyster, Christoph Plass, Heiko Becker, Michael Lübbert	8
5	Oncogenic KrasG12D Activation in the Nonhematopoietic Bone Marrow Microenvironment Causes Myelodysplastic Syndrome in Mice 2021 ·Molecular Cancer Research ·Lena Oßwald, Shaima’a Hamarsheh, Franziska Maria Uhl, Geoffroy Andrieux, Claudius Klein, Christine Dierks, Sandra Duquesne, Lukas M. Braun, Annette Schmitt‐Graeff, Justus Duyster, Melanie Boerries, Tilman Brummer, Robert Zeiser	8
6	Existence of reprogrammed lymphoma stem cells in a murine ALCL-like model 2020 ·Leukemia ·Stefanie Kreutmair, (unknown), Teresa Poggio, Geoffroy Andrieux, Alexander Keller, Cornelius Miething, Marie Follo, Dietmar Pfeifer, Khalid Shoumariyeh, Claudia Lengerke, Irene González-Menéndez, Falko Fend, Robert Zeiser, Suzanne D. Turner, Leticia Quintanilla-Martı́nez, Melanie Boerries, Justus Duyster, Anna Lena Illert	4
7	MicroRNA-146a regulates immune-related adverse events caused by immune checkpoint inhibitors 2020 ·JCI Insight ·(unknown), (unknown), (unknown), (unknown), Justyna Rawluk, Annette Schmitt‐Graeff, Federico Simonetta, (unknown), (unknown), Manching Ku, Sandra Duquesne, Konrad Aumann, David Rafei‐Shamsabadi, Frank Meiß, (unknown), Melanie Boerries, Robert S. Negrin, Justus Duyster, Robert Zeiser, Natalie Köhler	64
8	Prognostic factors for survival after allogeneic transplantation in acute lymphoblastic leukemia 2020 ·Bone Marrow Transplantation ·Christine Greil, Monika Engelhardt, Gabriele Ihorst, Jesús Duque‐Afonso, Khalid Shoumariyeh, Hartmut Bertz, Reinhard Marks, Robert Zeiser, Justus Duyster, Jürgen Finke, Ralph Wäsch	14
9	A novel conditional NPM-ALK-driven model of CD30+ T-cell lymphoma mediated by a translational stop cassette 2019 ·Oncogene ·Khalid Shoumariyeh, (unknown), Teresa Poggio, (unknown), (unknown), (unknown), (unknown), Dietmar Pfeifer, (unknown), Stefanie Kreutmair, Martina Rudelius, Leticia Quintanilla-Martı́nez, Falko Fend, Anna Lena Illert, Justus Duyster, Cornelius Miething	2
10	CBP Modulates Sensitivity to Dasatinib in Pre-BCR+ Acute Lymphoblastic Leukemia 2018 ·Cancer Research ·Jesús Duque‐Afonso, (unknown), Kyuho Han, David W. Morgens, Edwin E. Jeng, Ziming Weng, (unknown), Stephen H.K. Wong, Li Zhu, Michael C. Wei, Hee-Don Chae, Martin Schrappe, Gunnar Cario, Justus Duyster, Xiangshu Xiao, Kathleen M. Sakamoto, Michael C. Bassik, Michael L. Cleary	12
11	Anti-Angiogenics: Current Situation and Future Perspectives 2018 ·Oncology Research and Treatment ·Katja Zirlik, Justus Duyster	164
12	Epigenetic Modifications of the Bone Marrow (BM) Niche in Multiple Myeloma (MM) - a Three-Dimensional (3D) in Vitro Approach 2017 ·Blood ·Stefan J. Müller, Dagmar Wider, Andreas Thomsen, Marie Follo, Johannes M. Waldschmidt, Gabriele Ihorst, Sandra Maria Dold, (unknown), Johanna Senger, Julia Schüler, Justus Duyster, Abdel Kareem Azab, Martin J. Hug, Manfred Jung, Ralph Wäsch, Monika Engelhardt	1
13	Progression of Mds to Aml Features Gain of Single Driver Mutations with Consequent Changes in Clonal Composition and Occurrence of Multiple Clones with Mutations in Identical Genes 2017 ·Haematologica ·(unknown), (unknown), (unknown), (unknown), Maja Rothenberg‐Thurley, (unknown), (unknown), Katarzyna Szarc vel Szic, (unknown), Alexandra Nieters, (unknown), Justus Duyster, Michael Lübbert, Julius Wehrle, Klaus H. Metzeler, Rainer Claus, (unknown)	0
14	MicroRNA-155–deficient dendritic cells cause less severe GVHD through reduced migration and defective inflammasome activation 2015 ·Blood ·Sophia Chen, Benjamin Smith, Joseena Iype, (unknown), Dietmar Pfeifer, Sebastian Grundmann, Annette Schmitt‐Graeff, Marco Idzko, (unknown), Gabriele Prinz, Jürgen Finke, Justus Duyster, Robert Zeiser	84
15	Detection of Mutant Free Circulating Tumor DNA in the Plasma of Patients with Gastrointestinal Stromal Tumor Harboring Activating Mutations of CKIT or PDGFRA 2013 ·Clinical Cancer Research ·Jacqueline Maier, Thoralf Lange, Irina Kerle, Katja Specht, Melanie Bruegel, Claudia Wickenhauser, Philipp J. Jost, Dietger Niederwieser, Christian Peschel, Justus Duyster, Nikolas von Bubnoff	60
16	Sequential Inhibitor Therapy in CML: In Vitro Simulation Elucidates the Pattern of Resistance Mutations after Second- and Third-Line Treatment 2013 ·Clinical Cancer Research ·Robert C. Bauer, (unknown), Christian Peschel, Justus Duyster, Nikolas von Bubnoff	7
17	CBL Exon 8/9 Mutants Activate the FLT3 Pathway and Cluster in Core Binding Factor/11q Deletion Acute Myeloid Leukemia/Myelodysplastic Syndrome Subtypes 2009 ·Clinical Cancer Research ·Carola Reindl, Hilmar Quentmeier, Konstantin Petropoulos, Philipp A. Greif, Tobias Benthaus, Bob Argiropoulos, Gudrun Mellert, Sridhar Vempati, Justus Duyster, Christian Buske, Stefan K. Bohlander, R. Keith Humphries, Wolfgang Hiddemann, Karsten Spiekermann	89
18	Functional Analysis of Epidermal Growth Factor Receptor (EGFR) Mutations and Potential Implications for EGFR Targeted Therapy 2009 ·Clinical Cancer Research ·Rama Krishna Kancha, Nikolas von Bubnoff, Christian Peschel, Justus Duyster	133
19	FMS-Like Tyrosine Kinase 3–Internal Tandem Duplication Tyrosine Kinase Inhibitors Display a Nonoverlapping Profile of Resistance Mutations In vitro 2009 ·Cancer Research ·Nikolas von Bubnoff, Richard A. Engh, (unknown), (unknown), Christian Peschel, Justus Duyster	89
20	Enhanced Activation of Epidermal Growth Factor Receptor Caused by Tumor-Derived E-Cadherin Mutations 2008 ·Cancer Research ·Anja Bremm, Axel Walch, Margit Fuchs, Jörg Mages, Justus Duyster, Gisela Keller, Christine Hermannstädter, Karl‐Friedrich Becker, Sandra Rauser, Rupert Langer, Claus Hann von Weyhern, Heinz Höfler, Birgit Luber	62

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact